Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussain Contractor

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
Cell Metabolism|March 13, 2012
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathwayHouman Ashrafian, Gabor Czibik, Mohamed Bellahcene, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
Cell Metabolism|March 13, 2012
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathwayHouman Ashrafian, Gabor Czibik, Mohamed Bellahcene, et al.
Pageof 3